Tiziana Life Sciences Announces Platform Presentation of New

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology - Tiziana Life Sciences (NASDAQ:TLSA)

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced an

Related Keywords

Colorado , United States , Denver , American , Irina Koffler , Paul Spencer , Meeting Of The American Academy Neurology , Lifesci Advisors , Tiziana Life Sciences Ltd , Business Development , Tiziana Life Sciences , Life Sciences , Nasal Foralumab Dampens Microglial Activation , Stabilizes Clinical Progression , Non Active Secondary Progressive , Clinical Decision , Annual Meeting , American Academy , Sci Advisors ,